Skip to main content

Skip to main content

News
Contact

About us
Our Pipeline
- Zerlasiran
- Divesiran
Our Technology
Partnering
Patients
Investors
Careers

Site Search

Search query

About us
Our Pipeline
- Zerlasiran
- Divesiran
Our Technology
Partnering
Patients
Investors
Careers

NASDAQ: SLN

Quarterly Reports

Home / Investors / Financials / Quarterly Reports

Year

Stay Connected

Quick Links

About Us
Our Pipeline
Our Technology
Patients
Investors

Quick Links

SEC Filings
Investor FAQs
Information Request Form
Corporate Site

Contact

Corporate Headquarters

United Kingdom
12 Hammersmith Grove
London, W6 7AP

United States
221 River Street
9th Floor
Hoboken, NJ 07030

Germany
Robert-Rossle-Str. 10
D-13125 Berlin
+49 30 9489 2800

IR Contact

Gem Hopkins
Head of IR & Corporate Communications

IR@silence-therapeutics.com

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Silence Therapeutics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Silence Therapeutics to send you the requested Investor Email Alert updates.

* Required

Email Address *

Unsubscribe

Mailing Lists *

Press Releases

Events

Presentations

SEC Filings

End of Day Stock Quote

Email Alert Sign Up Confirmation

Stay Connected

Cookie Preferences

© Silence Therapeutics . All Rights Reserved.

Terms of Use
Privacy and Cookie Notice

Powered By Q4 Inc. 5.168.1.2 (opens in new window)